Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie-Anne Boivin-Proulx

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Scientific Reports|September 9, 2023
Association between cardiovascular diseases and dementia among various age groups: a population-based cohort study in older adultsLaurie-Anne Boivin-Proulx, Judith Brouillette, Marc Dorais, et al.
CJC Open|May 2, 2022
Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin Among Obese Patients With Atrial FibrillationLaurie-Anne Boivin-Proulx, Brian J Potter, Marc Dorais, et al.
CJC Open|January 26, 2023
Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary InterventionLaurie-Anne Boivin-Proulx, Brian J Potter, Marc Dorais, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older AdultsSylvie Perreault, Laurie-Anne Boivin Proulx, Judith Brouillette, et al.
CJC Open|October 18, 2022
Prehospital STEMI Referral Systems and Sex-Related Bias in Canada: A National SurveyLaurie-Anne Boivin-Proulx, Christine Pacheco, Alexis Matteau, et al.
World Journal of Nephrology|January 17, 2024
Effectiveness and safety of apixaban and rivaroxaban <i>vs</i> warfarin in patients with atrial fibrillation and chronic kidney diseaseSylvie Perreault, Laurie-Anne Boivin Proulx, Aurélie Lenglet, et al.
CJC Open|June 7, 2024
Potent P2Y<sub>12</sub> Inhibitor Selection and De-escalation Strategies in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Systematic Review and Meta-analysisLaurie-Anne Boivin-Proulx, Kevin R Bainey, Guillaume Marquis-Gravel, et al.
Pharmacology Research & Perspectives|November 22, 2022
Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillationAurélie Lenglet, Jakub Z Qazi, Laurie-Anne Boivin Proulx, et al.
Scientific Reports|November 19, 2022
Polypharmacy and risk of mortality among patients with heart failure following hospitalization: a nested case-control studySylvie Perreault, Mireille E Schnitzer, Eliane Disso, et al.
CJC Open|September 10, 2021
Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines UptakeMarie-Claude Beaulieu, Laurie-Anne Boivin-Proulx, Alexis Matteau, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Scientific Reports|September 9, 2023
Association between cardiovascular diseases and dementia among various age groups: a population-based cohort study in older adultsLaurie-Anne Boivin-Proulx, Judith Brouillette, Marc Dorais, et al.
CJC Open|May 2, 2022
Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin Among Obese Patients With Atrial FibrillationLaurie-Anne Boivin-Proulx, Brian J Potter, Marc Dorais, et al.
CJC Open|January 26, 2023
Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary InterventionLaurie-Anne Boivin-Proulx, Brian J Potter, Marc Dorais, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older AdultsSylvie Perreault, Laurie-Anne Boivin Proulx, Judith Brouillette, et al.
CJC Open|October 18, 2022
Prehospital STEMI Referral Systems and Sex-Related Bias in Canada: A National SurveyLaurie-Anne Boivin-Proulx, Christine Pacheco, Alexis Matteau, et al.
World Journal of Nephrology|January 17, 2024
Effectiveness and safety of apixaban and rivaroxaban <i>vs</i> warfarin in patients with atrial fibrillation and chronic kidney diseaseSylvie Perreault, Laurie-Anne Boivin Proulx, Aurélie Lenglet, et al.
CJC Open|June 7, 2024
Potent P2Y<sub>12</sub> Inhibitor Selection and De-escalation Strategies in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Systematic Review and Meta-analysisLaurie-Anne Boivin-Proulx, Kevin R Bainey, Guillaume Marquis-Gravel, et al.
Pharmacology Research & Perspectives|November 22, 2022
Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillationAurélie Lenglet, Jakub Z Qazi, Laurie-Anne Boivin Proulx, et al.
Scientific Reports|November 19, 2022
Polypharmacy and risk of mortality among patients with heart failure following hospitalization: a nested case-control studySylvie Perreault, Mireille E Schnitzer, Eliane Disso, et al.
CJC Open|September 10, 2021
Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines UptakeMarie-Claude Beaulieu, Laurie-Anne Boivin-Proulx, Alexis Matteau, et al.
Pageof 4